Brief: Virpax Announces Positive Results Of Swine Model Pilot Study For Probudur
10/07/2024 12:47
July 10 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX ANNOUNCES POSITIVE RESULTS OF SWINE MODEL PILOT
STUDY FOR
PROBUDUR™
* VIRPAX PHARMACEUTICALS INC - CONTINUE TO TARGET END OF
YEAR FOR
FILING OUR INVESTIGATIONAL NEW DRUG APPLICATION (IND) FOR
PROBUDUR
Source text for Eikon: ID:nBw2PBJP0a
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study